1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Comparison of patients with low and high HIR^{^a}
Characteristics Low HIR (n = 122) High HIR (n = 122) P Value
    Age 70 (56–79) 71 (60–79) .446
    Male (No.) (%) 55 (45) 83 (68) <.001
    Hypertension (No.) (%)^{^b} 68 (57) 66 (55) .685
    Diabetes mellitus (No.) (%)^{^b} 12 (10) 20 (17) .142
    Hyperlipidemia (No.) (%)^{^b} 31 (26) 40 (33) .251
    Current smoking (No.) (%)^{^c} 23 (20) 25 (21) .771
    Systolic BP (mm Hg) 149 (139–163) 156 (139–173) .141
    Diastolic BP (mm Hg) 82 (71–89) 81 (70–93) .990
    Serum glucose (mmol/L)^{^d} 6.1 (5.4–7.0) 6.5 (5.5–7.9) .038
    NIHSS^{^b} score 11 (7–17) 16 (11–21) <.001
Baseline MRI 
    Onset-to-MRI time (min) 112 (86–153) 112 (84–156) .838
    Proximal occlusion (No.) (%) 81 (66) 80 (66) .893
    DWI₁ volume (mL) 8 (4–19) 41 (16–96) <.001
    Tmax >6-sec volume (mL) 44 (17–85) 115 (56–147) <.001
    Tmax >10-sec volume (mL) 9 (2–22) 52 (27–75) <.001
    PWI-DWI mismatch (No.) (%) 85 (70) 59 (48) <.001
    FVH score (No.) (%) .016^{^e}
        0–1 6 (5) 13 (11) 
        2–3 30 (25) 33 (27) 
        4–5 54 (44) 59 (48) 
        6–7 32 (26) 17 (14) 
24-hr follow-up 
    NIHSS score^{^f} 6 (2–15) 14 (7–20) <.001
    ENI (No.) (%)^{^f} 51 (42) 27 (22) .001
    DWI₂ volume (Ml) 18 (9–45) 87 (33–161) <.001
    Infarct growth (Ml) 6 (1–26) 29 (10–75) <.001
    Complete recanalization (No.) (%) 40 (33) 45 (37) .502
3-mo mRS ≤ 1 (No.) (%)^{^g} 49 (45) 25 (21) <.001
3-mo mRS ≤ 2 (No.) (%)^{^g} 63 (58) 51 (44) .033
Note:—BP indicates blood pressure; ENI, early neurologic improvement.
↵a Unless specified, numbers are median (interquartile range).
↵b Missing data for 4 patients.
↵c Missing data for 9 patients.
↵d Missing data for 13 patients.
↵e P for Trend.
↵f Missing data for 5 patients.
↵g Missing data for 18 patients.